|1.||Park, Kwang-Kyun: 2 articles (01/2012 - 07/2009)|
|2.||Hwang, Young Sun: 2 articles (01/2012 - 07/2009)|
|3.||Chung, Won-Yoon: 2 articles (01/2012 - 07/2009)|
|4.||Park, Hee-Juhn: 2 articles (07/2009 - 11/2008)|
|5.||Joh, Eun-Ha: 1 article (04/2011)|
|6.||Kim, Dong-Hyun: 1 article (04/2011)|
|7.||Seo, Jeong Yeon: 1 article (07/2009)|
|8.||Park, Sun Kyu: 1 article (07/2009)|
|9.||Lee, Kyung-Tae: 1 article (11/2008)|
|10.||Choi, Jung-Hye: 1 article (11/2008)|
04/01/2011 - "Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways."
04/01/2011 - "Kalopanaxsaponin A may improve inflammatory diseases, such as colitis, by inhibiting IRAK-1 activation."
04/01/2011 - "Kalopanaxsaponin A, a triterpenoid saponin isolated from Kalopanax pictus (family Araliaceae), potently inhibited nuclear factor-kappa B (NF-κB) activation in lipopolysaccharide (LPS)-stimulated peritoneal macrophages during a screening programme for anti-colitis agents from natural products. "
|2.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/01/2012 - "Kalopanaxsaponin A inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking."
01/01/2012 - "The present study was performed to determine the anti-invasive effect of Kalopanaxsaponin A (KPS-A) on matrix metalloproteinase-9 (MMP-9)-meidated invasion in phorbol 12-myristate 13-acetate (PMA)-stimulated human oral squamous cell carcinoma (OSCC) cells and a murine xenograft model of human OSCC. "
|3.||Lewis Lung Carcinoma
03/01/2001 - "These results indicated that kalopanaxsaponin A has potential anti-tumor applications."
03/01/2001 - "Kalopanaxsaponin A is a basic saponin structure for the anti-tumor activity of hederagenin monodesmosides."
03/01/2001 - "Among glycosides of hederagenin, disaccharide (kalopanaxsaponin A, commonly also called alpha-hederin), trisaccharide (kalopanaxsaponin I), and tetrasaccharide (sapindoside C) showed significant cytotoxicity on several types of tumor cells, while hederagenin itself exhibited only weak cytotoxicity and its monosaccharide (delta-hederin) was non-cytotoxic. "
|1.||Matrix Metalloproteinase 9 (Gelatinase B)
|4.||Caspase 8 (Caspase-8)
|5.||NF-kappa B (NF-kB)
|7.||Interleukin-6 (Interleukin 6)
|1.||Heterologous Transplantation (Xenotransplantation)